Skip to content

Cohort study on efficacy and safety of Xiaoshi tablets in the treatment of urinary calculi

Cohort study on efficacy and safety of Xiaoshi tablets in the treatment of urinary calculi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000619
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary calculus

Interventions

Non-exposed group:none
Exposed group:Take Xiaoshi tablets

Sponsors

Conson Pharmaceutical Group
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Meet the relevant diagnostic criteria of urinary calculi; 2) The imaging examination confirmed the diagnosis of urinary calculi and the diameter of calculi was =6mm; 3) In line with the indications of drug stone removal; Age 18-70 years old, gender is not limited; 5) Voluntarily sign informed consent, with a certain degree of compliance.

Exclusion criteria

Exclusion criteria: 1) Complicated with cerebral infarction, coronary heart disease, pulmonary edema, liver cirrhosis, tumor and various mental diseases; 2) has been diagnosed with urinary system anatomical abnormalities (such as pyeloureteral junction stenosis); (3) CT indicates that the renal pelvis or ureter is obviously dilated and effusion; 4) Recently participated in other drug researchers; (5) Prepare women during pregnancy, lactation and pregnancy; 6) Patients who were judged by the investigator to be unable to join the study.

Design outcomes

Primary

MeasureTime frame
Clinical effective rate;

Secondary

MeasureTime frame
TCM syndrome scale;Patient evaluation questionnaire;Recurrence rate;Stone removal rate;VAS;

Countries

China

Contacts

Public ContactLI Jing

Dongzhimen Hospital, Beijing University of Chinese Medicine

natashalee@163.com13671131943

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026